EDF (Électricité de France) is a French multinational electric utility company, largely owned by the French state. It is one of the world's largest producers of electricity, primarily through its extensive fleet of nuclear power plants. While its core business is energy generation, transmission, and distribution, EDF plays a critical role in the pharmaceutical and healthcare sectors as a primary producer of medical isotopes used in cancer treatment and diagnostics. Through its subsidiary Framatome (specifically Framatome Healthcare), EDF leverages its nuclear infrastructure to produce radioisotopes like Cobalt-60 and Lutetium-177. These materials are essential for the sterilization of medical equipment and the development of targeted radionuclide therapies (radiopharmaceuticals). The company is currently expanding its 'nuclear medicine' footprint to address global shortages of therapeutic isotopes.
CLASSIFICATION
Company Type:CDMO
Therapeutic Areas:
Industry:Energy / Utilities
Sub-Industry:Nuclear Medicine Supply / Radiopharmaceuticals
SIZE & FINANCIALS
Employees:10000+
Revenue:€139.7B (2023)
Founded:1946
Ownership:government
Status:operating
FUNDING
Total Raised:N/A
Investors:French State (100%)
STOCK
Exchange:Delisted (formerly Euronext Paris)
Market Cap:N/A (Fully nationalized in 2023)
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial (Isotope Supply)
Modalities:Radiopharmaceuticals, Medical Isotopes
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:Government of France
Subsidiaries:Framatome (Framatome Healthcare), Enedis, Dalkia, EDF Renewables, Luminus
Key Partnerships:Novartis (Supply of isotopes for radiopharmaceuticals), NorthStar Medical Radioisotopes (Collaboration on Lu-177 production), Orano (Nuclear fuel cycle and isotope logistics), CEA (French Alternative Energies and Atomic Energy Commission)
COMPETITION
Position:Leader
Competitors:Orano, Bruce Power, Ontario Power Generation (OPG), Curium, IRE (Institute for Radioelements)
LEADERSHIP
Key Executives:
Luc Rémont - Chairman and CEO
Xavier Ursat - Senior Executive VP, Strategy, Technology, Innovation and New Nuclear
Bernard Fontana - CEO of Framatome
Board Members:Luc Rémont, Bruno Bensasson, Anne-Laurence Petel, Philippe Marien
LINKS
Website:edf.fr
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with EDF. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.